BiomX
PHGE
12 hedge funds and large institutions have $12.8M invested in BiomX in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
22% more capital invested
Capital invested by funds: $10.5M → $12.8M (+$2.27M)
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
8% less funds holding
Funds holding: 13 → 12 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$335K |
| 2 |
Jane Street
New York
|
+$39K |
| 3 |
JP Morgan Chase
New York
|
+$892 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$99.9K |
| 2 |
Renaissance Technologies
New York
|
-$82.1K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $5.43M | – | – | – |
|
|
JJ
2
Johnson & Johnson
New Brunswick,
New Jersey
| $4.12M | – | – | – |
|
|
MI
3
MMCAP International
Grand Cayman,
Cayman Islands
| $1.32M | – | – | – |
|
|
KC
4
Kepos Capital
New York
| $870K | – | – | – |
|
|
RA
5
Royce & Associates
New York
| $619K | +$335K | +1,126 | +200% |
|
|
6
Millennium Management
New York
| $188K | -$99.9K | -336 | -40% |
|
|
BCM
7
Bridgeway Capital Management
Houston,
Texas
| $113K | -$62.5K | -210 | -40% |
|
|
8
Jane Street
New York
| $48K | +$39K | +131 | New |
|
|
9
Renaissance Technologies
New York
| $46K | -$82.1K | -276 | -69% |
|
10
BlackRock
New York
| $11K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $3K | -$8.92K | -30 | -79% |
|
|
12
JP Morgan Chase
New York
| $1K | +$892 | +3 | New |
|
|
13
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$25K | -82 | Closed |
|
14
Morgan Stanley
New York
| – | -$6K | -21 | Closed |
|
PHGE Hedge Fund Activity: Q1 2022 in Review
12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q1 2022, worth a combined $12.8M — up 22% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PHGE and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Royce & Associates, adding an estimated $335K. The largest seller was Millennium Management, cutting an estimated $99.9K.
- 12 institutional investors held BiomX (PHGE) as of Q1 2022, down from 13 in Q4 2021.
- Funds reported $12.8M of BiomX stock for Q1 2022, up 22% quarter-over-quarter.
- 2 funds opened new BiomX positions in Q1 2022 and 3 closed out, a net change of -1 holder.
- The largest BiomX buyer in Q1 2022 was Royce & Associates, an estimated $335K added.
- The largest BiomX seller in Q1 2022 was Millennium Management, an estimated $99.9K sold.
Based on aggregated 13F filings for Q1 2022.